Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Sertraline Plus Relapse Prevention Therapy (RP) for the Treatment of Pathological Gambling With Comorbid Abuse or Dependence

NCT00249431 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00249431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Sertraline Plus Relapse Prevention Therapy (RP) for the Treatment of Pathological Gambling With Comorbid Abuse or Dependence
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2001
Completion date
December 31, 2005
Enrollment
9 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism, gambling